Aurinia Pharmaceuticals Inc. (AUPH)

NASDAQ: AUPH · Real-Time Price · USD

14.31

+0.36 (2.58%)

At close: Mar 16, 2026, 4:00 PM EDT

14.10

-0.21 (-1.47%)

After-hours: Mar 16, 2026, 7:50 PM EDT

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Research, Development and Commercialization of Therapeutic Drugs	283.06M	235.13M	175.51M	134.03M	45.61M
Research, Development and Commercialization of Therapeutic Drugs Growth	20.38%	33.97%	30.95%	193.89%	-9.00%
Total	283.06M	235.13M	175.51M	134.03M	45.61M
Total Growth	20.38%	33.97%	30.95%	193.89%	-9.00%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
United States	263.84M	210.10M	157.96M	102.46M	45.49M
United States Growth	25.58%	33.01%	54.17%	125.25%	-
Japan	19.21M	25.04M	17.56M	31.48M	-
Japan Growth	-23.26%	42.63%	-44.24%	-	-
Other	-	-	-	89.00K	117.00K
Other Growth	-	-	-	-23.93%	-0.85%
Total	283.06M	235.13M	175.51M	134.03M	45.61M
Total Growth	20.38%	33.97%	30.95%	193.89%	-9.00%

Source: S&P Global Market Intelligence.